Risk Factors for Infection, Predictors of Severe Disease, and Antibody Response to COVID-19 in Patients With Inflammatory Rheumatic Diseases in Portugal—A Multicenter, Nationwide Study
2022; Frontiers Media; Volume: 9; Linguagem: Inglês
10.3389/fmed.2022.901817
ISSN2296-858X
AutoresAna Rita Cruz-Machado, Sofia Barreira, Matilde Bandeira, Marc Veldhoen, Andréia Gomes, Marta Serrano, Cátia Duarte, Eurico Seabra, Bruno Miguel Fernandes, S. Garcia, F. Oliveira Pinheiro, Miguel Bernardes, Nathalie Madeira, Cláudia Miguel, Rita Pinheiro Torres, Ana Bento da Silva, Jorge Pestana, Diogo Esperança Almeida, Carolina Mazeda, F. Cunha Santos, Patrícia Pinto, Marlene Sousa, Hugo Parente, Graça Sequeira, María José Santos, João Eurico Fonseca, Vasco C. Romão,
Tópico(s)Long-Term Effects of COVID-19
ResumoTo identify risk factors for SARS-CoV-2 infection and for severe/critical COVID-19, and to assess the humoral response after COVID-19 in these patients.
Referência(s)